FOUZEE SugarLin HERBAL FORMULA capsules recall
FDA recall D-0207-2025 · initiated Dec 16, 2024
SHOPPERS- PLAZA recalled FOUZEE SugarLin HERBAL FORMULA capsules in Dec 2024 — an FDA Class I recall (D-0207-2025) because Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide.
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide
Sold unapproved, or found to contain something undeclared
The product should not have been on sale in this form — often a supplement found to contain a hidden prescription drug.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 172 180-count bottles
Details
- Product
- FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7
- Recalling company
- SHOPPERS- PLAZA
- Classification
- Class I
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide via internet sales
- Initiated
- Dec 16, 2024
- FDA report date
- Jan 29, 2025
Frequently asked
- Was FOUZEE SugarLin HERBAL FORMULA capsules recalled?
- SHOPPERS- PLAZA recalled FOUZEE SugarLin HERBAL FORMULA capsules in Dec 2024 — an FDA Class I recall (D-0207-2025) because Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide. Most serious — a reasonable probability that use will cause serious harm or death.
- Why was FOUZEE SugarLin HERBAL FORMULA capsules recalled?
- Per the FDA enforcement record, the reason for recall D-0207-2025 was: Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide
- Is a recalled FOUZEE SugarLin HERBAL FORMULA capsules dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of FOUZEE SugarLin HERBAL FORMULA capsules are affected?
- Distributed: Nationwide via internet sales. The recall covers these lots — Batch # 001, exp. date 09/10/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0207-2025.